Lazarus Monday, 05/28/07 08:55:25 PM Re: Lebaneseproud post# 521 Post # of 569 from the last Q: The Company continues to sell its products on a direct basis to customers in the United States as well as to seventeen different countries around the world. In addition the Company has formed the following distribution avenues: The Company has a nonexclusive worldwide distribution agreement with MP Biomedicals, Inc., Costa Mesa, CA. Under the agreement, MP Biomedicals is marketing Celox’ TCMTM, TCH™, TM-235™ serum replacement products as well as Cellvation™. MP Biomedicals manufactures and markets medical and biotechnology products worldwide. In 1997, the Company began providing its proprietary products to Sigma Chemical Company (NASDAQ:SIAL), St. Louis, MO. under a private label distribution agreement for worldwide distribution. The Company’s Celox product line is distributed in Japan through Funakoshi Co., LTD, a well-established Japanese distributor. The Company also has distribution of its STEMSOLTM and DMSO/Dextran products in Europe and the Pacific Rim through various non-exclusive agreements with local distributors.